Cogan's sign in a patient with suspected post-COVID-19 vaccine-associated myasthenia gravis - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/37283341/
The Cogan's sign is indicative of myasthenia gravis. This is the first report of neurological signs in a patient with post-COVID-19 vaccine-associated myasthenia gravis in Brazil. In this case, a...
Discussion: This case report demonstrated neurological signs in a patient with post-COVID-19 vaccine-associated myasthenia gravis. To our knowledge, this is the first report of post-COVID-19 vaccine-associated myasthenia gravis in Brazil.
Health-related quality of life (HRQoL) and psychological impact of the COVID-19 pandemic on patients with myasthenia gravis - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/37287657/
The aim of this study was to compare the effects of the pandemic on health-related quality of life (HRQoL), anxious-depressive symptoms, feelings of loneliness, and fear of COVID-19 between people...
Conclusions/Relevance: The harmful effect of the COVID-19 pandemic was greater in the MG group, and the perceived fear of COVID-19 had also a greater impact among this group, which has increased its negative effect on their psychosocial health.
Assessing facial weakness in myasthenia gravis with facial recognition software and deep learning - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/37292032/
Patterns of facial weakness can be detected with facial recognition software. Second, this study delivers a 'proof of concept' for a DL model that can distinguish MG from HC and...
Interpretation: Patterns of facial weakness can be detected with facial recognition software. Second, this study delivers a ‘proof of concept’ for a DL model that can distinguish MG from HC and classifies disease severity.
Mortality of myasthenia gravis: a national population-based study in China - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/37212271/
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site. The site is secure....
Interpretation: In China, MG-related mortality was notably high among adolescent males and the elderly. The increasing death burden due to MG highlight challenges to disease management.
Efficacy of apraclonidine eye drops in treating ptosis secondary to myasthenia gravis: A pilot clinical trial - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/37259693/
Apraclonidine may alleviate ptosis secondary to MG and may be an effective alternative treatment for this group of patients.
Discussion: Apraclonidine may alleviate ptosis secondary to MG and may be an effective alternative treatment for this group of patients.